Embecta Corp (EMBC NASDAQ) stock market data APIs
$15.1909
-0.05(-0.3%)
as of September 17, 2025
Try our APIs with
free plan!
Embecta Corp Financial Data Overview
Price chart is built with
Anychart
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Prev. Close
15.1909
Open
15.1444
High
15.6643
Low
15.0534
52 wk Range
9.1049-20.5833
Market Cap
881 M
P/E Ratio
10.6056
Shares Outstanding
58 485 K
Revenue
1 102 M
EPS
1.12
Dividends (Yield)
0.0398
Beta
1.081
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Embecta Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Embecta Corp data using free add-ons & libraries
Get Embecta Corp Fundamental Data
Embecta Corp Fundamental data includes:
- Net Revenue: 1 102 M
- EBITDA: 111 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-08
- EPS/Forecast: 0.77
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Embecta Corp News
New
Best Income Stocks to Buy for September 15th
Here are three stocks with buy rank and strong income characteristics for investors to consider today, September 15th: Citizens & Northern Corp CZNC: This bank holding company which also provides cre...
New Strong Buy Stocks for September 15th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Ranger Energy Services RNGR: This company which is a provider of well service rigs and services primarily in the United States...
Best Value Stocks to Buy for September 9th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 9th: Jackson Financial Inc. JXN: This insurance company which provides a suite of annui...
Insulin Delivery Device Company Evaluation Report 2025 | Embecta, Novo Nordisk, and Ypsomed Lead with Innovative Injection and Digital Management Solutions
Company Logo The Insulin Delivery Devices Companies Quadrant presents a detailed analysis of the global insulin delivery devices market, spotlighting the top 25 companies like Embecta Corp, Novo Nord...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
